PMC:7555630 / 12470-12912 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T12","span":{"begin":13,"end":17},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma9712"}],"text":"On the other hand, Antonini and colleagues reported on the outcomes of 10 PD patients affected by COVID-19 at the Parkinson and Movement Disorders unit in Italy and at King’s College Hospital in London, and suggested that PD patients, particularly those who are older and on advanced therapies, should be considered as a specifically susceptible group because of the high mortality rate noted for this subset of patients in their series [15]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T6","span":{"begin":13,"end":17},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0002398"}],"text":"On the other hand, Antonini and colleagues reported on the outcomes of 10 PD patients affected by COVID-19 at the Parkinson and Movement Disorders unit in Italy and at King’s College Hospital in London, and suggested that PD patients, particularly those who are older and on advanced therapies, should be considered as a specifically susceptible group because of the high mortality rate noted for this subset of patients in their series [15]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T108","span":{"begin":74,"end":76},"obj":"Disease"},{"id":"T109","span":{"begin":98,"end":106},"obj":"Disease"},{"id":"T110","span":{"begin":128,"end":146},"obj":"Disease"},{"id":"T111","span":{"begin":222,"end":224},"obj":"Disease"}],"attributes":[{"id":"A108","pred":"mondo_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/MONDO_0005180"},{"id":"A109","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0005395"},{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0005180"}],"text":"On the other hand, Antonini and colleagues reported on the outcomes of 10 PD patients affected by COVID-19 at the Parkinson and Movement Disorders unit in Italy and at King’s College Hospital in London, and suggested that PD patients, particularly those who are older and on advanced therapies, should be considered as a specifically susceptible group because of the high mortality rate noted for this subset of patients in their series [15]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T56","span":{"begin":319,"end":320},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"On the other hand, Antonini and colleagues reported on the outcomes of 10 PD patients affected by COVID-19 at the Parkinson and Movement Disorders unit in Italy and at King’s College Hospital in London, and suggested that PD patients, particularly those who are older and on advanced therapies, should be considered as a specifically susceptible group because of the high mortality rate noted for this subset of patients in their series [15]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T22","span":{"begin":74,"end":76},"obj":"Chemical"},{"id":"T23","span":{"begin":222,"end":224},"obj":"Chemical"},{"id":"T24","span":{"begin":346,"end":351},"obj":"Chemical"}],"attributes":[{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_74756"},{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_74756"},{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"On the other hand, Antonini and colleagues reported on the outcomes of 10 PD patients affected by COVID-19 at the Parkinson and Movement Disorders unit in Italy and at King’s College Hospital in London, and suggested that PD patients, particularly those who are older and on advanced therapies, should be considered as a specifically susceptible group because of the high mortality rate noted for this subset of patients in their series [15]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T76","span":{"begin":114,"end":123},"obj":"Phenotype"},{"id":"T77","span":{"begin":128,"end":146},"obj":"Phenotype"}],"attributes":[{"id":"A76","pred":"hp_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/HP_0001300"},{"id":"A77","pred":"hp_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/HP_0100022"}],"text":"On the other hand, Antonini and colleagues reported on the outcomes of 10 PD patients affected by COVID-19 at the Parkinson and Movement Disorders unit in Italy and at King’s College Hospital in London, and suggested that PD patients, particularly those who are older and on advanced therapies, should be considered as a specifically susceptible group because of the high mortality rate noted for this subset of patients in their series [15]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T80","span":{"begin":0,"end":442},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"On the other hand, Antonini and colleagues reported on the outcomes of 10 PD patients affected by COVID-19 at the Parkinson and Movement Disorders unit in Italy and at King’s College Hospital in London, and suggested that PD patients, particularly those who are older and on advanced therapies, should be considered as a specifically susceptible group because of the high mortality rate noted for this subset of patients in their series [15]."}

{"project":"2_test","denotations":[{"id":"32962001-32347572-44896011","span":{"begin":438,"end":440},"obj":"32347572"}],"text":"On the other hand, Antonini and colleagues reported on the outcomes of 10 PD patients affected by COVID-19 at the Parkinson and Movement Disorders unit in Italy and at King’s College Hospital in London, and suggested that PD patients, particularly those who are older and on advanced therapies, should be considered as a specifically susceptible group because of the high mortality rate noted for this subset of patients in their series [15]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"391","span":{"begin":77,"end":85},"obj":"Species"},{"id":"392","span":{"begin":225,"end":233},"obj":"Species"},{"id":"393","span":{"begin":412,"end":420},"obj":"Species"},{"id":"411","span":{"begin":74,"end":76},"obj":"Disease"},{"id":"412","span":{"begin":98,"end":106},"obj":"Disease"},{"id":"413","span":{"begin":114,"end":146},"obj":"Disease"},{"id":"414","span":{"begin":222,"end":224},"obj":"Disease"},{"id":"415","span":{"begin":372,"end":381},"obj":"Disease"}],"attributes":[{"id":"A391","pred":"tao:has_database_id","subj":"391","obj":"Tax:9606"},{"id":"A392","pred":"tao:has_database_id","subj":"392","obj":"Tax:9606"},{"id":"A393","pred":"tao:has_database_id","subj":"393","obj":"Tax:9606"},{"id":"A411","pred":"tao:has_database_id","subj":"411","obj":"MESH:D010300"},{"id":"A412","pred":"tao:has_database_id","subj":"412","obj":"MESH:C000657245"},{"id":"A413","pred":"tao:has_database_id","subj":"413","obj":"MESH:D010302"},{"id":"A414","pred":"tao:has_database_id","subj":"414","obj":"MESH:D010300"},{"id":"A415","pred":"tao:has_database_id","subj":"415","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"On the other hand, Antonini and colleagues reported on the outcomes of 10 PD patients affected by COVID-19 at the Parkinson and Movement Disorders unit in Italy and at King’s College Hospital in London, and suggested that PD patients, particularly those who are older and on advanced therapies, should be considered as a specifically susceptible group because of the high mortality rate noted for this subset of patients in their series [15]."}